41: MUM’s: Acuity RM Group & ValiRx | Defence Contracts, AI & Biotech Growth #ACRM #VAL #AEG #BZT #SVML #SVNS #PNPL #GMET
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
In this week's Monday Upbeat Markets, Graham Dickson, Kevin Hornsby, Charles Archer and Justin Pitchford are joined by David Rajakovich of Acuity RM Group (#ACRM) to discuss growing defence contracts, recurring revenues, international expansion and the upcoming launch of its AI-powered cybersecurity platform, Virilis.
Mark Eccleston, CEO of ValiRx (#VAL), joins the team to explore the company's evolving biotech strategy, its McGill University cancer research programme, the potential value of its Ambrose Healthcare stake and plans to fund drug development through separate investment vehicles.
Justin then takes us through the charts, with market commentary and technical analysis covering #ACRM #VAL #AEG #BZT #SVML #SVNS #PNPL #GMET.
00:16:21 #ARCM Interview
00:36:18 #VAL Interview
01:07:01 The Charts
01:07:05 Acuity RM Group plc #ACRM
01:08:30 ValiRx plc #VAL
01:10:54 Active Energy Group plc #AEG
01:15:18 Bezant Resources plc #BZT
01:18:40 Sovereign Metals Limited #SVML
01:22:43 Solvonis Therapeutics plc #SVNS
01:24:01 Pineapple Power Corporation plc #PNPL
01:26:37 Guardian Metal Resources plc #GMET
New episodes every Monday evening — video on YouTube, audioboom, Spotify & Apple.
👇 Subscribe and turn on notifications so you never miss a Monday.
📧 Want to appear on a future episode? Email us at MondayUpbeatMarkets@gmail.com
Disclaimer & Declaration of Interest
This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information and views provided are for general informational purposes only and should not be construed as a solicitation to buy or sell any financial products related to the companies discussed. Any opinions or comments are made to the best of the knowledge and belief of the commentators; however, no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion. Listeners are encouraged to perform their own research and consult with a licensed professional before making any financial decisions based on the content of this podcast